Health
Regenxbio Aims for FDA Approval
Regenxbio plans to submit its Duchenne gene therapy for FDA approval, following a request for another trial. The move comes as the agency continues to analyze youth tobacco data.
Coverage timeline — 2 articles
STAT News
Government can't restrict SNAP dollars on candy, diminishing returns for IVF add-ons, and other health news
2026-06-24 11:53 UTC
STAT News
Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to see another trial.
2026-06-24 11:55 UTC